- Appointment of Agent for Service of Process and Undertaking (F-X)
2010年12月1日 - 6:46AM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
F-X
APPOINTMENT
OF AGENT FOR SERVICE OF
PROCESS
AND UNDERTAKING
A.
|
Name
of issuer or person filing (“Filer”):
YM BioSciences
Inc.
|
B.
|
(1)
|
This
is (check one):
|
|
x
|
An
original filing for the Filer.
|
|
o
|
An
amended filing for the Filer.
|
|
(2)
|
Check
the following box if you are filing the Form F-X in paper in accordance
with Regulation S-T Rule 101(b)(9)
|
C.
|
Identify
the filing in conjunction with which this form is being
filed:
|
Name
of registrant:
|
YM
BioSciences Inc.
|
Form
type:
|
Form
F-10
|
File
number (if known):
|
333-170872
|
Filed
by:
|
YM
BioSciences Inc.
|
Date
filed (if filed concurrently, so indicate):
|
November
30, 2010 (filed concurrently)
|
D.
|
The
Filer is incorporated or organized under the laws of
Nova Scotia, Canada,
and
has its principal place of business at
Suite 400, Building 11, 5045
Orbitor Drive, Mississauga, Ontario, Canada L4W 4Y4;
telephone
(905)
629-9761.
|
E.
|
Filer
designates and appoints
YM BioSciences USA Inc.
(“Agent”), located at
P.O. Box 21747, Lehigh Valley, Pennsylvania 18002; telephone
(610) 560-0600
as the agent of the Filer upon whom may be served
any process, pleadings, subpoenas, or other papers
in:
|
|
(a)
|
any
investigation or administrative proceeding conducted by the Commission;
and
|
|
(b)
|
any
civil suit or action brought against the Filer or to which the Filer has
been joined as defendant or respondent, in any appropriate court in any
place subject to the jurisdiction of any state or of the United States, or
of any of its territories or possessions or of the District of Columbia,
where the investigation, proceeding or cause of action arises out of or
relates to or concerns any offering made or purported to be made in
connection with the securities registered or qualified by the Filer on
Form F-10 on November 30, 2010 or any purchases or sales of any
security in connection therewith. The Filer stipulates and
agrees that any such civil suit or action or administrative proceeding may
be commenced by the service of process upon, and that the service of an
administrative subpoena shall be effected by service upon such agent for
service of process, and that the service as aforesaid shall be taken and
held in all courts and administrative tribunals to be valid and binding as
if personal service thereof had been
made.
|
F.
|
The
Filer stipulates and agrees to appoint a successor agent for service of
process and file an amended Form F-X if the Filer discharges the Agent or
the Agent is unwilling or unable to accept service on behalf of the Filer
at any time until six years have elapsed from the date the issuer of the
securities to which the Form F-10 relates has ceased reporting under the
Exchange Act.
|
|
The
Filer further undertakes to advise the Commission promptly of any change
to the Agent’s name or address during the applicable period by amendment
of this form, referencing the file number of the relevant form in
conjunction with which the amendment is being
filed.
|
G.
|
The
Filer undertakes to make available, in person or by telephone,
representatives to respond to inquiries made by the Commission staff, and
to furnish promptly, when requested to do so by the Commission staff,
information relating to: the Form F-10; the securities to which the Form
F-10 relates; and the transactions in such
securities.
|
SIGNATURES
The Filer
certifies that it has duly caused this power of attorney, consent, stipulation
and agreement to be signed on its behalf by the undersigned, thereunto duly
authorized, in Mississauga, Ontario, Canada, on November 30, 2010.
|
YM
BIOSCIENCES INC.
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Nick
Glover
|
|
|
|
Nick
Glover
|
|
|
|
President
& Chief Executive Officer
|
|
This
statement has been signed by the following person in the capacity indicated on
November 30, 2010.
|
YM
BIOSCIENCES USA INC.
|
|
as
Agent for Service of Process for YM BioSciences Inc.
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Nick
Glover
|
|
|
|
Nick
Glover
|
|
|
|
President
|
|
YM Biosciences (AMEX:YMI)
過去 株価チャート
から 6 2024 まで 7 2024
YM Biosciences (AMEX:YMI)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about YM Biosciences Ordinary Shares (Canada) (アメリカ証券取引所): 0 recent articles
その他のニュース記事